Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a pistacia oil spray beat saline for stuffy noses?

NCT ID NCT07266688

First seen Dec 10, 2025 · Last updated Jun 21, 2026 · Updated 29 times

Summary

This study tested a nasal spray made from pistacia lentiscus oil (Bactorinol) against plain saline in 100 adults with vasomotor rhinitis, a condition causing chronic nasal congestion and runny nose. Participants used the spray three times daily for 20 days. Researchers measured changes in nasal airflow, symptoms, and quality of life to see if the natural oil spray offers extra relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASOMOTOR RHINITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Università di Urbino Carlo Bo

    Urbino, Pesaro E Urbino, 61029, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Pistacia lentiscus oil (Bactorinol nasal spray)

What this could lead to

If it works, this could offer a natural, non-drug option to ease nasal congestion and runny nose in people with vasomotor rhinitis.

What could go wrong

This is a small, completed trial with 100 participants. The results may not apply to everyone, and the spray may not work better than saline.

Conditions

The condition(s) this trial relates to.

vasomotor rhinitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.